betamethasone dipropionate 0.643 MG/ML / calcipotriene 0.05 MG/ML Topical Suspension
RxNorm concept 833461, clinical drug (scd). Prescribable name: betamethasone dipropionate 0.0643 % / calcipotriene 0.005 % Topical Suspension.
- RxCUI
- 833461
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/833461 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
betamethasone dipropionate 0.0643 % / calcipotriene 0.005 % Topical Suspension
Related concepts
- calcipotriene 0.05 MG/ML (SCDC, consists of)
- betamethasone dipropionate 0.643 MG/ML (SCDC, consists of)
- Topical Suspension (DF, has dose form)
- betamethasone dipropionate 0.643 MG/ML / calcipotriene 0.05 MG/ML Topical Suspension [Taclonex] (SBD, has tradename)
- betamethasone dipropionate 0.643 MG/ML / calcipotriene 0.05 MG/ML Topical Suspension [Attero] (SBD, has tradename)
Linked data
NDCs
- 00713084860
- 00713084892
- 45802088918
- 45802088996
- 51672140204
- 51672140208
- 63629861801
- 63629861901
- 63646004012
- 63646004060
- 66993093761
- 66993093778
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 833461 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/833461 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 833461. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.